中国医学装备
中國醫學裝備
중국의학장비
CHINA MEDICAL EQUIPMENT
2012年
7期
66-68
,共3页
腰椎间盘突出症%臭氧消融术%微创%体层摄影术,X线计算机
腰椎間盤突齣癥%臭氧消融術%微創%體層攝影術,X線計算機
요추간반돌출증%취양소융술%미창%체층섭영술,X선계산궤
Lumbar vertebral disc herniation%Ozone ablation technique%Small wound cure Tomography%X-ray computed
目的:探讨微创臭氧消融术治疗腰椎间盘突出症疗效。方法:在对146例患者行微创臭氧消融术中,通过CT机或者C型臂X光机显示屏调整穿刺方向,确保穿刺部位,分别于盘内及突出物中央和盘外注射臭氧。结果:146例患者均在CT或者C型臂X光机引导下穿刺成功,成功率为100%,均治愈出院。对146例治愈患者进行术后随访,统计其疗效:优76例(占52.O%)、良52例(占35.6%)、可16例(占10.9%)、差2例(占1.6%)9优良率为87.6%,未发生下肢瘫痪、静脉栓塞等严重并发症。结论:微创臭氧消融术治疗腰椎间盘突出症安全、有效,可以作为腰椎间盘突出症介入治疗的重要方式,值得临床推广。
目的:探討微創臭氧消融術治療腰椎間盤突齣癥療效。方法:在對146例患者行微創臭氧消融術中,通過CT機或者C型臂X光機顯示屏調整穿刺方嚮,確保穿刺部位,分彆于盤內及突齣物中央和盤外註射臭氧。結果:146例患者均在CT或者C型臂X光機引導下穿刺成功,成功率為100%,均治愈齣院。對146例治愈患者進行術後隨訪,統計其療效:優76例(佔52.O%)、良52例(佔35.6%)、可16例(佔10.9%)、差2例(佔1.6%)9優良率為87.6%,未髮生下肢癱瘓、靜脈栓塞等嚴重併髮癥。結論:微創臭氧消融術治療腰椎間盤突齣癥安全、有效,可以作為腰椎間盤突齣癥介入治療的重要方式,值得臨床推廣。
목적:탐토미창취양소융술치료요추간반돌출증료효。방법:재대146례환자행미창취양소융술중,통과CT궤혹자C형비X광궤현시병조정천자방향,학보천자부위,분별우반내급돌출물중앙화반외주사취양。결과:146례환자균재CT혹자C형비X광궤인도하천자성공,성공솔위100%,균치유출원。대146례치유환자진행술후수방,통계기료효:우76례(점52.O%)、량52례(점35.6%)、가16례(점10.9%)、차2례(점1.6%)9우량솔위87.6%,미발생하지탄탄、정맥전새등엄중병발증。결론:미창취양소융술치료요추간반돌출증안전、유효,가이작위요추간반돌출증개입치료적중요방식,치득림상추엄。
Objective: To explore the clinical effect of ozone in treating lumbar disc hemiation(LDH). Methods: We adjusted the puncture direction by display of CT or C ann X-ray machine, to ensure accurate puncture and to take-up injection ozone respectively in the disc and protrusions central. Results: All 146 patients were guided by puncture successfully in CT or C arm X-ray machine (100%), all cured and discharged. All the follow-up, statistical curative effect: Optimal 76 cases (52.0%), good 52 cases (35.6%), not bad 16 cases (10.9%), and bad in 2 (1.6%) ,the rate of choiceness was 87.6% (128/146)and did not happen lower limb paralysis, vein thrombosis and other severe complications.Conclusion: Small wound cure Ozone ablation technique prolapse of lumbar intervertebral disc safe, effective, and can be used as a prolapse of lumbar intervertebral disc intervention treatment important ways, worth clinical promotion.